Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Track TRIB with free AI briefings, catalyst countdowns, and dilution alerts.

TRIB · TRINITY BIOTECH PLC

Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.

$5.1M Cash on Hand
10.4mo Cash Runway
Follow TRIB by email Get an email when TRIB reports key news in an SEC filing, pushes back a promised milestone, files for a stock offering, lands on the Downside Radar or has an FDA decision. Free, no account needed.

We send one confirmation email first. Only emails about TRIB, unsubscribe in one click. Privacy

📣 What TRIB Says Is Next

Quoted word for word from the company's press releases filed with the SEC. Timing is the company's own guidance, not a BioRadar estimate.

📄 Latest SEC Filings in Plain English

Each summary is written by AI from the filing itself, and one that names a number or a name the filing does not contain is not shown. Quarterly and annual reports are listed by period. Read the filing before acting on it.

🧪 Trial & FDA Catalysts

📊 Drug Pipeline

DrugIndicationMost advanced trialStatus
Determine the presence and concentration of CBD… Generalized Anxiety Disorder Early Phase 1 · NCT06656806 Unknown
Measure concentrations of CBD in spot urine… Generalized Anxiety Disorder Early Phase 1 · NCT06656806 Unknown

Source: ClinicalTrials.gov trials sponsored by the company, one row per candidate at its most advanced registered trial. FDA approvals: Drugs@FDA. Wrong or missing drug? Report it

💰 Cash Runway & Dilution Risk

TRIB holds $5.1M in cash and short-term investments and burns about $1.5M/quarter from operations, an estimated runway of 10.4 months at that rate (BioRadar estimate, not company guidance).

Dilution pressure: 55 · Elevated

Recent financing filings on SEC EDGAR:

Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when TRIB files for a raise →

👥 Who Owns TRIB

Insiders 0.1% Other 5%+ holders 18.9% Institutions 14.5% Public and other holders 66.5%
HolderTypeShares% of sharesAs of
MiCo IVD Holdings, LLC 5%+ holder (13D) 69,450,720 18.56% 2025-12-08
Perceptive Advisors LLC Institution (13G, 5%+) 54,148,590 14.47% 2026-11-06
Novus Diagnostics Ltd. 5%+ holder (13G) 1,119,988 0.30% 2025-12-23
Ronan O'Caoimh
Director
Insider 486,208 0.13% 2026-03-18
John Gillard
Director
Insider 10,000 0.00% 2026-03-18

Share count 374,206,640 (latest 10-Q/10-K). Insiders: each officer's, director's and 10% owner's latest Form 3, 4 or 5, direct and indirect shares; options are not counted. 5%+ holders: latest Schedule 13D or 13G of each holder above 5%. Institutions: the largest 13F holders. Sources have different dates, so the split is approximate. Source: SEC EDGAR.

Get the full TRIB picture

The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for TRIB and every other ticker you follow. Card required, cancel anytime.

Start 7-day free trial →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.